Home > Newsletters > International Pharmaceutical Regulatory Monitor > Global Recall System May be Part of U.S. FDA International Pivot
International Pharmaceutical Regulatory Monitor
November 2012 | Vol. 40 No. 11
Global Recall System May be Part of U.S. FDA International Pivot
SEATTLE — The U.S. Food and Drug Administration’s (FDA) Office of International Programs (OIP) is exploring development of a single, global recall system that would encompass all domestic and international recalls.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.